Internal Medicine, Endocrinology, Diabetes, & Metabolism · Edinburg, TX
NPI
1073959326
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4113 Crosspoint Blvd # 11
Edinburg, TX, 78539
Phone (956) 603-1555
Groups this clinician bills Medicare through
Medicare paid, 2024
$167K
9,879 services
Medicare patients, 2024
228
Average age 72
Drug cost, 2024
$9.1M
4,828 prescriptions
Company payments, 2025
$299K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eduardo D Luna was code 99214 (office e&m - established), 484 times for 202 patients. In total Eduardo D Luna billed 9,879 services in 31 codes, and Medicare paid $167K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 484 | 202 | $85.50 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 236 | 141 | $11.46 | $2,705 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 173 | 23 | $36.50 | $6,315 |
| 95251 Test - Miscellaneous | Office | 147 | 65 | $23.69 | $3,482 |
| 99458 E&M - Miscellaneous | Office | 135 | 21 | $29.96 | $4,045 |
| 99457 E&M - Miscellaneous | Office | 111 | 25 | $37.09 | $4,117 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 106 | 23 | $47.77 | $5,064 |
| 99215 Office E&M - Established | Office | 92 | 65 | $119.07 | $11K |
| 96372 Injection Administration | Office | 72 | 20 | $10.45 | $752 |
| 99454 E&M - Miscellaneous | Office | 59 | 18 | $35.01 | $2,066 |
| 83036 Blood Count | Office | 30 | 27 | $9.52 | $286 |
| 99205 Office E&M - New | Office | 23 | 23 | $151.95 | $3,495 |
| 99204 Office E&M - New | Office | 22 | 22 | $104.29 | $2,294 |
| 76536 Ultrasound - Nonspecific | Office | 21 | 19 | $72.02 | $1,512 |
| 95250 Test - Miscellaneous | Office | 15 | 14 | $108.88 | $1,633 |
By year: 2022 $64K for 909 services; 2023 $85K for 1,574 services; 2024 $167K for 9,879 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 30 | 27 | $9.52 | $286 |
Medicare prescription drug claims, 2024
In 2024, the drug Eduardo D Luna prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 797 prescriptions and refills. In total Eduardo D Luna wrote 4,828 Medicare prescriptions that cost $9.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 797 | 1,043 | 177 | $1.1M |
| Levothyroxine Sodium Generic | 354 | 986 | 131 | $4,036 |
| Pioglitazone Hcl Generic | 323 | 842 | 131 | $4,033 |
| Ozempic Semaglutide | 230 | 356 | 74 | $328K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 195 | 429 | 69 | $231K |
| Dexamethasone Generic | 135 | 135 | 119 | $99.89 |
| Jardiance Empagliflozin | 133 | 290 | 50 | $162K |
| Korlym Mifepristone | 120 | 120 | 24 | $4.7M |
| Atorvastatin Calcium Generic | 116 | 332 | 51 | $1,309 |
| Tresiba Flextouch U-200 Insulin Degludec | 109 | 234 | 49 | $76K |
| Liothyronine Sodium Generic | 101 | 293 | 35 | $3,663 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 86 | 161 | 24 | $119K |
| Testosterone Cypionate Generic | 77 | 89 | 14 | $1,787 |
| Rosuvastatin Calcium Generic | 70 | 206 | 32 | $990 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 67 | 146 | 27 | $51K |
Brand drugs: 2,791 claims; generic drugs: 1,738 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eduardo D Luna $299K ($299K in general payments such as food, travel and fees) from 29 companies. The largest payer was Corcept Therapeutics with $87K.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 110 | $87K |
| Lilly USA, LLC LLY | 131 | $77K |
| Recordati_rare_diseases_inc. | 52 | $35K |
| Alexion Pharmaceuticals, Inc. AZN | 43 | $23K |
| Insulet Corporation PODD | 48 | $23K |
| Madrigal Pharmaceuticals MDGL | 16 | $20K |
| Dexcom, Inc. DXCM | 19 | $12K |
| Xeris Pharmaceuticals, Inc. | 15 | $8,077 |
| Abbott Laboratories ABT | 22 | $5,587 |
| CeQur Corporation | 3 | $3,767 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.